Literature DB >> 28877016

Buprenorphine for the Neonatal Abstinence Syndrome.

Walter K Kraft1, Susan C Adeniyi-Jones1, Michelle E Ehrlich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28877016      PMCID： PMC6424493          DOI： 10.1056/NEJMc1709121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Ethanol in liquid preparations intended for children.

Authors: 
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

Review 2.  Ethanol pharmacokinetics in neonates and infants.

Authors:  Elizabeth Marek; Walter K Kraft
Journal:  Curr Ther Res Clin Exp       Date:  2014-10-22
  2 in total
  3 in total

1.  Could Postnatal Age-Related Uridine Diphosphate Glucuronic Acid Be a Rate-Limiting Factor in the Metabolism of Morphine During the First Week of Life?

Authors:  Tao Liu; Tamorah R Lewis; Jason N Moore; Walter K Kraft; Estelle B Gauda; David Sartori; David E Moody; Jogarao V S Gobburu; Vijay Ivaturi
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-05-10

2.  Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome.

Authors:  Rena Eudy-Byrne; Nicole Zane; Susan C Adeniyi-Jones; Marc R Gastonguay; Ana Ruiz-Garcia; Gagan Kaushal; Walter K Kraft
Journal:  Clin Transl Sci       Date:  2021-09-16       Impact factor: 4.438

3.  Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.

Authors:  Mary Beth Sutter; Hannah Watson; Nicole Yonke; Sherry Weitzen; Lawrence Leeman
Journal:  BMC Pediatr       Date:  2022-06-15       Impact factor: 2.567
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.